These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38488340)

  • 1. Adverse drug reactions from adrenaline auto-injectors: Data from the French poison control centres.
    Pouessel G; Tournoud C; Gautier S; Nisse P; Tanno LK
    Clin Exp Allergy; 2024 Jun; 54(6):435-437. PubMed ID: 38488340
    [No Abstract]   [Full Text] [Related]  

  • 2. Unintentional Epinephrine Auto-injector Injuries: A National Poison Center Observational Study.
    Anshien M; Rose SR; Wills BK
    Am J Ther; 2019; 26(1):e110-e114. PubMed ID: 27984266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse drug reactions from adrenaline auto-injectors: Analysis of the French pharmacovigilance database.
    Pouessel G; Petitpain N; Tanno LK; Gautier S;
    Clin Exp Allergy; 2023 Sep; 53(9):955-958. PubMed ID: 37464961
    [No Abstract]   [Full Text] [Related]  

  • 4. Voluntarily reported unintentional injections from epinephrine auto-injectors.
    Simons FE; Edwards ES; Read EJ; Clark S; Liebelt EL
    J Allergy Clin Immunol; 2010 Feb; 125(2):419-423.e4. PubMed ID: 20159254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What are the 'ideal' features of an adrenaline (epinephrine) auto-injector in the treatment of anaphylaxis?
    Frew AJ
    Allergy; 2011 Jan; 66(1):15-24. PubMed ID: 20716315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adrenaline auto-injectors for the treatment of anaphylaxis with and without cardiovascular collapse in the community.
    Sheikh A; Simons FE; Barbour V; Worth A
    Cochrane Database Syst Rev; 2012 Aug; 2012(8):CD008935. PubMed ID: 22895980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How far from correct is the use of adrenaline auto-injectors? A survey in Italian patients.
    Ridolo E; Montagni M; Bonzano L; Savi E; Peveri S; Costantino MT; Crivellaro M; Manzotti G; Lombardi C; Caminati M; Incorvaia C; Senna G
    Intern Emerg Med; 2015 Dec; 10(8):937-41. PubMed ID: 25990486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adrenaline in anaphylaxis treatment and self-administration: experience from an inner city emergency department.
    Mostmans Y; Grosber M; Blykers M; Mols P; Naeije N; Gutermuth J
    Allergy; 2017 Mar; 72(3):492-497. PubMed ID: 27709624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epinephrine and its use in anaphylaxis: current issues.
    Simons KJ; Simons FE
    Curr Opin Allergy Clin Immunol; 2010 Aug; 10(4):354-61. PubMed ID: 20543673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anaphylaxis treatment: current barriers to adrenaline auto-injector use.
    Song TT; Worm M; Lieberman P
    Allergy; 2014 Aug; 69(8):983-91. PubMed ID: 24835773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epinephrine auto-injector use in adolescents at risk of anaphylaxis: a qualitative study in Scotland, UK.
    Gallagher M; Worth A; Cunningham-Burley S; Sheikh A
    Clin Exp Allergy; 2011 Jun; 41(6):869-77. PubMed ID: 21481022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-Management of Anaphylaxis Is Not Optimal.
    Múgica-García MV; Tejedor-Alonso MA; Moro-Moro M; Esteban-Hernández J; Rojas-Perez-Ezquerra PE; Vila-Albelda C; Rosado-Ingelmo A
    J Investig Allergol Clin Immunol; 2015; 25(6):408-15. PubMed ID: 26817137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying the factors and root causes associated with the unintentional usage of an adrenaline auto-injector in Japanese children and their caregivers.
    Sasaki K; Nakagawa T; Sugiura S; Ebisawa M; Ito K
    Allergol Int; 2018 Oct; 67(4):475-480. PubMed ID: 29519764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of suicide by self-injection of adrenaline.
    Palmiere C; Bévalot F; Malicier D; Grouzmann E; Fracasso T; Fanton L
    Forensic Sci Med Pathol; 2015 Sep; 11(3):421-6. PubMed ID: 26233937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic and pharmacodynamic evidence of adrenaline administered via auto-injector for anaphylactic reactions: A review of literature.
    Moss J; Jani Y; Edwards B; Tomlin S; Rashed AN
    Br J Clin Pharmacol; 2021 Mar; 87(3):816-824. PubMed ID: 32559814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emergency Treatment of Anaphylaxis in Japanese Beekeepers.
    Sato K; Hirata H; Tatewaki M; Shiromori S; Souma R; Satoh H; Sugiyama K; Arima M; Kurasawa K; Fukuda T; Fukushima Y
    J Agromedicine; 2020 Apr; 25(2):153-157. PubMed ID: 31566096
    [No Abstract]   [Full Text] [Related]  

  • 17. Is There an Optimal Training Interval to Improve the Correct Use of Adrenaline Auto-Injectors?
    Sirin Kose S; Asilsoy S; Tezcan D; Al S; Atay O; Kangalli O; Uzuner N; Karaman O
    Int Arch Allergy Immunol; 2020; 181(2):136-140. PubMed ID: 31794965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epinephrine auto-injectors: first-aid treatment still out of reach for many at risk of anaphylaxis in the community.
    Simons FE;
    Ann Allergy Asthma Immunol; 2009 May; 102(5):403-9. PubMed ID: 19492662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epinephrine auto-injector pandemic.
    Campbell RL; Manivannan V; Hartz MF; Sadosty AT
    Pediatr Emerg Care; 2012 Sep; 28(9):938-42. PubMed ID: 22940899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anaphylaxis management: the essential role of adrenaline (epinephrine) auto-injectors. Should PHARMAC fund them in New Zealand?
    Fitzharris P; Empson M; Ameratunga R; Sinclair J; Crump V; Steele R; Broom B
    N Z Med J; 2006 May; 119(1233):U1965. PubMed ID: 16680178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.